YOLFTbeta
Electrocore LLC

Electrocore LLC

ECOR · NASDAQ · Healthcare / Medical Devices

5.25USD-0.04 (-0.76%)

Price History

Full chart

Market Stats

Previous Close5.29
Open5.42
Day Range4.37 – 5.56
52-Week Range4.41 – 12.70
Volume290.84K
Market Cap100.26M
P/E (TTM)0.00
Forward P/E384.62
EPS-1.65
Dividend Yield0.00%
Beta1.01
50-Day Avg8.79
200-Day Avg7.23

About

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Thomas J. Errico M.D.
  • Employees83
  • Headquarters200 Forge Way, Rockaway, NJ, United States, 07866, USA
  • Websitehttps://www.electrocore.com

Leadership

  • Dr. Thomas J. Errico M.D.Founder & Independent Chairman · b. 1952
  • Mr. Michael FoxChief Operating Officer
  • Mr. Mitch DeshonVice President of Sales & New Market Development
  • Ms. Jennifer A. HayesVice President of HR & Employee Success
  • Dr. Peter S. Staats M.B.A., M.D.Chief Medical Officer · b. 1964
  • Ms. Amanda YanuklisChief of Staff
  • Mr. Andy BrownVice President & Corporate Controller

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue254.14K811.46K992.95K2.39M3.50M5.45M8.59M16.03M25.18M32.03M
Growth (%)-+219.30%+22.37%+140.72%+46.25%+55.93%+57.62%+86.57%+57.09%+27.20%
Cost of Revenue123.73K518.53K578.74K1.16M1.74M1.39M1.62M2.80M3.79M4.24M
Gross Profit130.41K292.93K414.21K1.23M1.76M4.07M6.98M13.23M21.40M27.79M
Gross Margin51.31%36.10%41.71%51.60%50.30%74.59%81.19%82.51%84.97%86.75%
Operating Expense15.14M25.94M54.97M47.32M26.51M24.11M29.85M32.03M33.56M40.94M
Operating Income-15.01M-25.64M-54.55M-46.09M-24.75M-20.04M-22.87M-18.80M-12.16M-13.15M
Operating Margin-5906.33%-3160.31%-5494.07%-1928.17%-707.94%-367.69%-266.22%-117.31%-48.30%-41.06%
EBITDA-14.96M-28.87M-54.49M-43.84M-23.88M-17.69M-22.33M-17.76M-10.72M-11.70M
EBITDA Margin-5885.31%-3558.20%-5487.36%-1834.16%-683.23%-324.47%-259.85%-110.79%-42.57%-36.52%
Net Income-15.74M-35.79M-55.82M-45.15M-23.51M-17.22M-22.16M-18.83M-11.89M-13.97M
Net Income Margin-6192.44%-4410.88%-5621.66%-1888.81%-672.55%-315.87%-257.94%-117.49%-47.20%-43.60%
R&D7.97M7.83M12.47M9.90M4.20M2.54M5.52M5.32M2.36M2.73M
R&D as % of Total Revenue3136.62%965.04%1255.46%414.27%120.18%46.52%64.25%33.19%9.37%8.54%
Interest Expense771.25K7.12M02.79M8.34K4.33M287.00K-389.00K590.00K
Interest Expense % of Total Revenue303.47%877.82%0.00%116.57%0.24%79.37%3.34%-1.54%1.84%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets622.02K39.23M73.50M35.46M31.52M42.83M24.76M16.10M20.47M18.67M
Total Liabilities61.68M128.70M7.32M10.56M7.87M6.18M7.67M8.66M12.93M20.38M
Total Equity-61.05M-90.07M65.55M24.26M23.01M36.65M17.09M7.44M7.54M-1.71M
Cash416.34K13.22M7.60M13.56M4.24M34.69M17.71M10.33M3.45M7.04M
Total Debt7.33M--2.02M2.83M761.00K699.00K626.00K4.14M9.40M
Net Debt3.25M-13.22M-7.60M-11.55M-1.41M-33.93M-17.01M-9.71M686.00K2.37M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-13.23M-25.33M-47.11M-45.07M-20.05M-13.63M-16.64M-14.67M-6.95M-8.19M
Investing Cash Flow-24.12M-24.12M-36.83M50.97M-7.96M18.22M--206.00K-8.52M3.88M
Financing Cash Flow9.27M62.49M78.33M160.84K18.90M25.68M-2.84K7.49M8.44M7.63M
Capital Expenditure152.53K152.53K278.92K69.67K000206.00K066.00K
Free Cash Flow-13.23M-25.48M-47.39M-45.14M-20.05M-13.63M-16.64M-14.87M-6.95M-8.25M
Dividends Paid--3.63B---00--
FCF to OCF100.00%100.60%100.59%100.15%100.00%100.00%100.00%101.40%100.00%100.81%
Dividend Paid to FCF---7658.05%---0.00%0.00%--

Earnings

Report DateMar 21, 2018Jun 25, 2018Aug 13, 2018Nov 13, 2018Mar 27, 2019May 14, 2019Aug 13, 2019Nov 13, 2019Mar 23, 2020May 14, 2020Aug 13, 2020Nov 12, 2020Mar 11, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Mar 10, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Mar 8, 2023May 3, 2023Aug 9, 2023Nov 8, 2023Mar 13, 2024May 8, 2024Aug 7, 2024Nov 13, 2024Mar 12, 2025May 7, 2025Aug 6, 2025Nov 5, 2025Mar 20, 2026May 6, 2026Aug 6, 2026Nov 4, 2026
EPS Estimate0.000.00-3.75-5.70-8.00-6.45-7.12-7.50-4.35-3.45-2.95-1.87-1.56-1.69-1.72-1.20-1.02-1.05-1.05-1.05-1.12-0.99-0.93-0.79-0.61-0.59-0.43-0.33-0.34-0.45-0.32-0.36-0.39-0.61-0.41-0.26
EPS Actual0.02-0.38-3.15-6.75-7.95-7.05-5.75-4.89-4.35-4.05-1.95-1.50-2.10-1.65-1.19-0.90-1.05-1.17-1.20-1.20-1.22-1.17-1.02-0.68-0.61-0.53-0.38-0.31-0.40-0.47-0.44-0.40-0.34-0.59-0.33-
Surprise--16.00%-18.42%0.63%-9.30%19.24%34.80%0.00%-17.39%33.90%19.79%-34.62%2.37%30.81%25.00%-2.94%-11.43%-14.29%-14.29%-8.93%-18.18%-9.68%13.92%0.00%10.17%11.63%6.06%-17.65%-4.44%-37.50%-11.11%13.38%3.28%19.51%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap100.26M
Enterprise Value102.57M
Trailing P/E0.00
Forward P/E384.62
Price / Sales2.71
Price / Book34.89
EPS-1.65
Book Value-0.31
Revenue (TTM)36.97M
Gross Profit (TTM)32.18M
EBITDA-13.66M
Profit Margin-39.96%
Operating Margin-29.33%
Return on Equity-478.70%
Return on Assets-55.00%
Shares Outstanding9.02M
Shares Float5.99M
Beta1.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 5 analystsTarget 19.17
  • Strong Buy
    3
  • Buy
    2

Ownership Breakdown

Institutions
11.64%
Insiders
35.30%
Retail / Other
53.06%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    202.64K2.25%
  • Balyasny Asset Management LLC
    116.46K1.29%
  • FourWorld Capital Management LLC
    94.00K1.04%
  • Wexford Capital LP
    92.06K1.02%
  • Geode Capital Management, LLC
    78.08K0.87%
  • JAFFETILCHIN INVESTMENT PARTNERS, LLC
    58.20K0.65%
  • Sontag Advisory LLC
    47.50K0.53%
  • Renaissance Technologies Corp
    44.41K0.49%
  • Citadel Advisors Llc
    43.80K0.49%
  • Vanguard Fiduciary Trust Co
    38.53K0.43%
  • International Assets Investment Management, LLC
    36.27K0.40%
  • HighTower Advisors, LLC
    35.34K0.39%
  • BlackRock Inc
    26.78K0.30%
  • State Street Corp
    26.52K0.29%
  • Emerald Investment Partners, LLC
    25.98K0.29%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    140.70K1.56%
  • Fidelity Extended Market Index
    32.33K0.36%
  • Bridgeway Ultra-Small Company
    25.00K0.28%
  • Abante Quant Value FI
    24.66K0.27%
  • iShares Micro-Cap ETF
    17.45K0.19%

Stock Splits

  • Feb 15, 20231:15